SpringWorks Therapeutics Inc. logo

SpringWorks Therapeutics Inc.

SWTX | NASDAQ
Chart Builder DCF Calculator
$46.99
$0 (0.00%)
At close: Jul 01, 2025, 04:00 PM ET

Market Data

Market Cap
$3.54B
Enterprise Value
$3.26B
Beta
0.70
Average Volume
N/A
Shares Outstanding (Diluted)
74.89M
Shares Change YoY
1.51%
Institutional Ownership
93.14%
Exchange
N/A
ISIN
N/A

Price Performance

Price Change 1M
N/A
Price Change 3M
N/A
Price Change 6M
N/A
Price Change YTD
N/A
Price Change 1Y
N/A
Price Change 3Y
N/A
Price Change 5Y
N/A
1M CAGR (ann.)
1.6%
1Y CAGR (ann.)
24.7%
5Y CAGR (ann.)
1.1%
All-Time CAGR
13.4%

Valuation

PE Ratio
-13.78
Forward PE
46.40
PEG Ratio
-0.34
Forward PEG
0.04
PS Ratio
16.12
Forward PS
4.20
PB Ratio
8.48
P/FCF Ratio
-20.31
P/Adj. FCF Ratio
-12.51
P/OCF Ratio
-19.83
EV/Sales
14.84
EV/EBIT
-12.19
EV/EBITDA
-12.44
EV/FCF
-18.70
Earnings Yield
-7.3%
FCF Yield
-4.9%
Adj. FCF Yield
-8.0%

Financial Health

Net Cash
$287.87M
Total Debt
$7.39M
Cash & Short-Term Investments
$287.87M
Total Assets
$505.36M
Current Ratio
3.81
Quick Ratio
3.70
Debt / Equity Ratio
0.02
Debt / EBITDA
-0.03
Debt / FCF
-0.04
OCF / Debt
-22.38
Interest Coverage
0.00
Altman Z-Score
20.08
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
93.5%
Operating Profit Margin
-120.5%
EBITDA Margin
-143.4%
Net Profit Margin
-134.7%
FCF Margin
-79.4%
Adj. FCF Margin
-128.8%
SBC / Revenue
57.0%
SBC Impact (per share)
-62.3%

Returns

Return on Assets
-44.0%
Return on Equity
-46.6%
Return on Invested Capital
-56.9%
Return on Capital Employed
-57.1%
Return on Tangible Assets
-45.1%

Historical Growth (CAGR)

Revenue CAGR 3Y
805.4%
Revenue CAGR 5Y
67.5%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
17.7%
EPS CAGR 5Y
-13.2%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
2.8%
FCF CAGR 5Y
-22.4%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
11
EPS Growth Next 3Y
48.7%
Revenue Growth Next 3Y
68.1%
Earnings Date
Aug 5, 2025
EPS Estimate (next Q)
-$0.81
EPS Growth Est (next Q)
50.0%
Revenue Est (next Q)
$73.39M
Revenue Growth Est (next Q)
22.9%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$65.40
Price Target Upside
39.2%

Cash Flow

Operating Cash Flow
$-165.43M
Free Cash Flow
$-174.33M
Adj. Free Cash Flow
$-282.96M
FCF Per Share
-$2.43
OCF Per Share
-$2.37
OCF/S Ratio
-91.7%

Income Statement

Revenue
$219.67M
Gross Profit
$204.8M
Operating Income
$-264.74M
EBITDA
$-262M
Net Income
$-253.93M
EPS (Diluted)
-$3.41
Revenue / Employee
N/A
Profit / Employee
N/A
Employees
N/A

© 2026 bestshares.com. All rights reserved.